Geoffrey M. Price - 07 Feb 2023 Form 4 Insider Report for Oak Street Health, Inc.

Role
Chief Innovation Officer, Director
Signature
/s/ Robert Guenthner, attorney-in-fact for Geoffrey Price
Issuer symbol
N/A
Transactions as of
07 Feb 2023
Net transactions value
-$13,629,520
Form type
4
Filing time
09 Feb 2023, 16:04:49 UTC
Previous filing
12 Jan 2023
Next filing
23 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OSH Common Stock, $0.001 par value Options Exercise $8,400,000 +400,000 +10% $21.00 4,274,863 07 Feb 2023 Direct F1
transaction OSH Common Stock, $0.001 par value Sale $13,629,520 -400,000 -9.4% $34.07 3,874,863 07 Feb 2023 Direct F1, F2
holding OSH Common Stock, $0.001 par value 1,073,270 07 Feb 2023 By Price-Uhl Living Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OSH Employee Stock Option (Right to Buy) Options Exercise $8,400,000 -400,000 -16% $21.00 2,149,281 07 Feb 2023 Common Stock, par value $0.001 400,000 $21.00 Direct F1, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.9883 to $34.0980, inclusive. The Reporting Person undertakes to provide to Oak Street Health, Inc., any security holder of Oak Street Health, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote (2).
F3 All options exercised by the Reporting Person as reported in this Form 4 were fully vested and exercisable at the time of the transaction.
F4 The reported securities include the aggregate options, all of which were issued at the time of the Issuer's initial public offering, held by the Reporting Person, a portion of which remains subject to vesting.